Colson, Philippe
Delerce, Jérémy
Burel, Emilie
Dahan, Jordan
Jouffret, Agnès
Fenollar, Florence
Yahi, Nouara
Fantini, Jacques
La Scola, Bernard
Raoult, Didier http://orcid.org/0000-0002-0633-5974
Funding for this research was provided by:
Agence Nationale de la Recherche (Méditerranée-Infection 10-IAHU-03)
Région Provence Alpes Côte d’Azur and Europe (FEDER PA 0000320 PRIMMI)
Emergen French consortium
Hitachi High-Technologies Corporation
Article History
Received: 21 December 2021
Accepted: 24 January 2022
First Online: 18 February 2022
Declarations
:
: Didier Raoult has a conflict of interest, having been a consultant for Hitachi High-Technologies Corporation, Tokyo, Japan, from 2018 to 2020. He is a scientific board member of Eurofins company and a founder of a microbial culture company (Culture Top). None of the other authors have conflicts of interest to declare. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
: This study has been approved by the ethics committee of University Hospital Institute (IHU) Méditerranée Infection (N°2021-029). Access to the patients’ biological and registry data issued from the hospital information system was approved by the data protection committee of Assistance Publique-Hôpitaux de Marseille (APHM) and was recorded in the European General Data Protection Regulation registry under number RGPD/APHM 2019-73.